Insiders Alkermes plc

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-07 EDT			5-day change	1st Jan Change
24.59 ^USD	+2.03%		+0.20%	-11.36%

05-02	UBS Adjusts Price Target on Alkermes to $21 From $23, Maintains Sell Rating	MT
05-01	Alkermes's Q1 Earnings, Revenue Grow But Miss Street View	MT

Alkermes Insider Sold Shares Worth $292,740, According to a Recent SEC Filing	03-19	MT
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors	03-07	CI
Alkermes plc Announces Executive Changes	02-05	CI
Alkermes plc Announces Changes to its Board	12-08	CI
Biogen shareholders back Susan Langer as director	23-06-26	RE
ISS recommends one of Sarissa's three nominees for Alkermes board	23-06-20	RE
ISS backs election of Langer to replace former Biogen director Denner	23-06-15	RE
Sarissa's Denner quits Biogen board as firm seeks seats at Alkermes	23-06-13	RE
Sarissa's Denner quits Biogen board as firm seeks seats at Alkermes	23-06-13	RE
Alkermes Names Caroline Loew Chief Executive Officer Designate of Planned Oncology Company	23-06-02	MT
Insider Sell: Alkermes	23-05-10	MT
Alkermes Files Preliminary Proxy Statement and Provides Update on Annual Director Nomination Process	23-05-08	PR
Insider Buy: Alkermes	22-11-16	MT
Insider Sell: Alkermes	22-06-21	MT
Alkermes plc Announces Management Changes	22-05-26	CI
Insider Sell: Alkermes	22-05-20	MT
Insider Sell: Alkermes	22-05-03	MT
Insider Sell: Alkermes	22-05-03	MT
Insider Sell: Alkermes	22-04-19	MT
Sarissa Capital Management LP Nominates Candidates to the Board of Alkermes plc	22-01-11	CI

No results for this search